Amedeo Smart

Free Medical Literature Service

 

Amedeo

Peptic Ulcer
  Free Subscription

Articles published in
Am J Gastroenterol
    June 2026
  1. DURU O, Santoni G, Holmberg D, Birgisson H, et al
    The effect of prior proton pump inhibitor use on gastric cancer survival: A population-based cohort study in the five Nordic countries.
    Am J Gastroenterol. 2026 Jun 9. doi: 10.14309/ajg.0000000000004075.
    >> Share

    April 2026
  2. HUNG KW
    Making Cents of the Cost of Helicobacter pylori Management.
    Am J Gastroenterol. 2026 Apr 10. doi: 10.14309/ajg.0000000000003990.
    >> Share

    March 2026
  3. SIRANART N, Chumpangern Y, Pajareya P, Nakaphan P, et al
    Endoscopic Management for Non-variceal Upper Gastrointestinal Bleeding: A Network Meta-analysis of Randomized Controlled Trials and Cost-Effectiveness Analyses of Two Healthcare Systems.
    Am J Gastroenterol. 2026 Mar 24. doi: 10.14309/ajg.0000000000004000.
    >> Share

    February 2026
  4. PATEL N, Silvey S, Bajaj JS
    Vonoprazan Is Associated with Better Liver-Related Outcomes Compared to Proton Pump Inhibitors In Cirrhosis.
    Am J Gastroenterol. 2026 Feb 10. doi: 10.14309/ajg.0000000000003945.
    >> Share

  5. KARLIN KL, Gilbert EH, Lim F, Agyekum AA, et al
    Proton Pump Inhibitors are More Cost-Effective than Potassium Competitive Acid Blockers for Gastroesophageal Reflux Disease.
    Am J Gastroenterol. 2026 Feb 10. doi: 10.14309/ajg.0000000000003943.
    >> Share

    January 2026
  6. OH JH, Kim HS, Cheung DY, Lee HL, et al
    Correction to: Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared to Esomeprazole in Erosive Esophagitis.
    Am J Gastroenterol. 2026 Jan 22. doi: 10.14309/ajg.0000000000003875.
    >> Share

  7. LIU L, Wang K, Neidecker MV, Yang H, et al
    Cost-effectiveness of first-line regimens for Helicobacter pylori infection in the United States.
    Am J Gastroenterol. 2026 Jan 21. doi: 10.14309/ajg.0000000000003924.
    >> Share

    October 2025
  8. DE FARIA MORAES B, Pedral Diniz Leite GA, Pedral Diniz Leite GA, Motta Fonseca ML, et al
    Reevaluating the Role of Proton Pump Inhibitors After Endoscopic Band Ligation of Esophageal Varices in Cirrhotic Patients: A Systematic Review and Meta-analysis.
    Am J Gastroenterol. 2025 Oct 21. doi: 10.14309/ajg.0000000000003800.
    >> Share

  9. ANTUNES C, Ghosh G, Katz P, Yadlapati R, et al
    Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Non-Erosive Reflux Disease.
    Am J Gastroenterol. 2025 Oct 13. doi: 10.14309/ajg.0000000000003794.
    >> Share

    August 2025
  10. ABE H, Hatta W, Tarasawa K, Hatayama Y, et al
    Effect of oral proton pump inhibitor administration on reducing the delayed bleeding risk in five upper gastrointestinal endoscopic treatments.
    Am J Gastroenterol. 2025 Aug 22. doi: 10.14309/ajg.0000000000003746.
    >> Share

    June 2025
  11. SHAH ED, Gyawali CP, Chan WW
    Optimizing the cost-effective evaluation of gastroesophageal reflux by typical symptom phenotypes after failure of empiric acid suppression trial.
    Am J Gastroenterol. 2025 Jun 5. doi: 10.14309/ajg.0000000000003576.
    >> Share

    May 2025
  12. HOWDEN CW
    The Role of P-CABs in GERD.
    Am J Gastroenterol. 2025;120:993-998.
    >> Share

    March 2025
  13. LAI SW, Liao KF
    Proton-Pump Inhibitor Use and Cardiovascular Adverse Event Risk.
    Am J Gastroenterol. 2025 Mar 31. doi: 10.14309/ajg.0000000000003381.
    >> Share

  14. YUAN C, Sun D, Lin XM
    Endoscopic diagnosis of gastropericardial fistula caused by intrathoracic gastric ulcer.
    Am J Gastroenterol. 2025 Mar 12. doi: 10.14309/ajg.0000000000003414.
    >> Share

    February 2025
  15. DEZA DC, Alcedo J, Lafuente M, Lopez FJ, et al
    PROBIOTICS PRESCRIBED WITH HELICOBACTER PYLORI ERADICATION THERAPY IN EUROPE: USAGE PATTERN, EFFECTIVENESS, AND SAFETY: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
    Am J Gastroenterol. 2025 Feb 4. doi: 10.14309/ajg.0000000000003351.
    >> Share

    December 2024
  16. SUN W, Wu K
    Metoclopramide May Not Decrease the Need for Second-Look Esophagogastroduodenoscopy in Patients With Overall Active Upper Gastrointestinal Bleeding.
    Am J Gastroenterol. 2024 Dec 10. doi: 10.14309/ajg.0000000000003189.
    >> Share

  17. KONG Q, Li Y
    When Subtraction Wins, What Are the Considerations for Addition in Helicobacter pylori Eradication?
    Am J Gastroenterol. 2024 Dec 4. doi: 10.14309/ajg.0000000000003183.
    >> Share

  18. FUJIWARA Y, Sawada A, Kobayashi Y, Hosomi S, et al
    Prevalence of Belching Disorders and Their Characteristics in the General Adult Population.
    Am J Gastroenterol. 2024;119:2526-2528.
    >> Share

  19. SAHA B, Verma A, Danielson AP, Ravi K, et al
    Gastrohepatic Fistula Secondary to Metastatic Colon Cancer as a Rare Etiology of Upper Gastrointestinal Bleed.
    Am J Gastroenterol. 2024;119:2365.
    >> Share

    November 2024
  20. CHAN WW, Sharma N, Gyawali CP
    The Role of Gastroesophageal Reflux in Airway Inflammation.
    Am J Gastroenterol. 2024 Nov 14. doi: 10.14309/ajg.0000000000003205.
    >> Share

    September 2024
  21. CHEY WD, Howden CW, Moss SF, Morgan DR, et al
    ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
    Am J Gastroenterol. 2024;119:1730-1753.
    >> Share

    August 2024
  22. MOSHOLDER AD, Hada M, Leishear K
    Proton pump inhibitors and cardiovascular adverse events: a meta-analysis of randomized controlled trials.
    Am J Gastroenterol. 2024 Aug 27. doi: 10.14309/ajg.0000000000003058.
    >> Share

    July 2024
  23. LUNAGARIYA Y, Shah M, Lad S, Chauhan S, et al
    Comparing Short-Term Dual vs Standard Quadruple Therapy for Helicobacter pylori Eradication.
    Am J Gastroenterol. 2024 Jul 17. doi: 10.14309/ajg.0000000000002882.
    >> Share

  24. OH JH, Kim HS, Cheung DY, Lee HL, et al
    Randomized, Double-blind, Active-controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan compared to Esomeprazole in Erosive Esophagitis.
    Am J Gastroenterol. 2024 Jul 3. doi: 10.14309/ajg.0000000000002929.
    >> Share

    June 2024
  25. HAN YM, Yoon JH, Yoo S, Chung SJ, et al
    Visceral Adipose Tissue Reduction Measured by Deep Neural Network Architecture Improved Reflux Esophagitis Endoscopic Grade.
    Am J Gastroenterol. 2024;119:1117-1125.
    >> Share

    April 2024
  26. KRAUSE AJ, Greytak M, Kaizer AM, Carlson DA, et al
    Diagnostic Yield of Ambulatory Reflux Monitoring Systems for Evaluation of Chronic Laryngeal Symptoms.
    Am J Gastroenterol. 2024;119:627-634.
    >> Share

    February 2024
  27. DU RC, Lu NH, Hu Y
    Is 10-Day Vonoprazan With High-Dose Amoxicillin Dual Therapy Efficient for Eradicating Helicobacter pylori Infection in China?
    Am J Gastroenterol. 2024 Feb 19. doi: 10.14309/ajg.0000000000002641.
    >> Share

  28. ZHUANG Q, Chen S, Zhou X, Jia X, et al
    Comparative efficacy of P-CABs versus proton pump inhibitors for Grade C/D esophagitis: A systematic review and network meta-analysis.
    Am J Gastroenterol. 2024 Feb 12. doi: 10.14309/ajg.0000000000002714.
    >> Share

  29. CHEN L, Wang R, Peng T, Ye L, et al
    Mantle Cell Lymphoma Presenting as Erosive Duodenitis.
    Am J Gastroenterol. 2024;119:240.
    >> Share

    January 2024
  30. CHEN F, Liu Y, Xing X, Yang J, et al
    An uncommon chest pain after endoscopic hemostasis of peptic ulcer.
    Am J Gastroenterol. 2024 Jan 15. doi: 10.14309/ajg.0000000000002652.
    >> Share

  31. YASUMURA K, Tochio T, Ohana M
    Refractory gastric ulcer in the antrum.
    Am J Gastroenterol. 2024 Jan 15. doi: 10.14309/ajg.0000000000002651.
    >> Share

    December 2023
  32. VIMONSUNTIRUNGSRI T, Thungsuk R, Nopjaroonsri P, Faknak N, et al
    The efficacy of metoclopramide for gastric visualization by endoscopy in patients with active upper gastrointestinal bleeding: double-blind randomized controlled trial.
    Am J Gastroenterol. 2023 Dec 7. doi: 10.14309/ajg.0000000000002620.
    >> Share

  33. ZAMANI M, Alizadeh-Tabari S, Chan WW, Talley NJ, et al
    Association Between Anxiety/Depression and Gastroesophageal Reflux: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2023;118:2133-2143.
    >> Share

    November 2023
  34. BUJANDA L, Nyssen OP, Ramos J, Bordin DS, et al
    Effectiveness of Helicobacter pylori treatments according to antibiotic resistance.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002600.
    >> Share

  35. YAN TL, Wang JH, He XJ, Zhu YB, et al
    Ten-day vonoprazan-amoxicillin dual therapy versus standard fourteen-day Bismuth-based quadruple therapy for first-line Helicobacter pylori eradication: a multicenter randomized clinical trial.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002592.
    >> Share

  36. ZULLO A, Gatta L, De Francesco V
    Randomized Controlled Trials for Helicobacter pylori Infection: What We Should Compare.
    Am J Gastroenterol. 2023;118:2094.
    >> Share

  37. KOUNTOURAS J
    Thinking of the Long Puzzling Issue of Several Suboptimal Treatments of Helicobacter pylori Infection.
    Am J Gastroenterol. 2023;118:2093.
    >> Share

    September 2023
  38. SHUNG DL, Lin JK, Laine L
    Achieving Value by Risk Stratification with Machine Learning Model or Clinical Risk Score in Acute Upper Gastrointestinal Bleeding: A Cost Minimization Analysis.
    Am J Gastroenterol. 2023 Sep 27. doi: 10.14309/ajg.0000000000002520.
    >> Share

    August 2023
  39. TAPPER EB, Zhao Z, Parikh ND
    An emulated clinical trial of deprescribing proton pump inhibitors in patients with cirrhosis.
    Am J Gastroenterol. 2023 Aug 10. doi: 10.14309/ajg.0000000000002462.
    >> Share

    June 2023
  40. GREENAN G, Rogers BD, Gyawali CP
    PROXIMAL GASTRIC PRESSURIZATION FOLLOWING SLEEVE GASTRECTOMY ASSOCIATES WITH GASTROESOPHAGEAL REFLUX.
    Am J Gastroenterol. 2023 Jun 19. doi: 10.14309/ajg.0000000000002374.
    >> Share

  41. CORAZZIARI ES, Gasbarrini A, D'Alba L, D'Ovidio V, et al
    Poliprotect vs Omeprazole in the relief of heartburn, epigastric pain and burning in patients without erosive esophagitis and gastro-duodenal lesions: A Randomized, Controlled Trial.
    Am J Gastroenterol. 2023 Jun 13. doi: 10.14309/ajg.0000000000002360.
    >> Share

    May 2023
  42. GRAHAM DY
    It Is Time for a Paradigm Shift in Design, Execution, and Publishing of Comparative Helicobacter pylori Treatment Trials.
    Am J Gastroenterol. 2023 May 15. doi: 10.14309/ajg.0000000000002298.
    >> Share

  43. CHITTAJALLU V, Vozzo C, Friedman K, Glessing B, et al
    Odynophagia Secondary to Mpox-Associated Esophageal Ulceration.
    Am J Gastroenterol. 2023;118:774.
    >> Share

    March 2023
  44. HSU PI, Chen KY, Tai WC, Yang JC, et al
    Hybrid, high-dose dual and bismuth quadruple therapies for first-line treatment of Helicobacter pylori infection in Taiwan: a multicenter, open-label, randomized trial.
    Am J Gastroenterol. 2023 Mar 20. doi: 10.14309/ajg.0000000000002255.
    >> Share

  45. DENG C, Wu S, Xu F, Zhou Z, et al
    Underwater anti-reflux mucosectomy for refractory gastroesophageal reflux disease:A rapid and simple technique for endoscopic treatment.
    Am J Gastroenterol. 2023 Mar 20. doi: 10.14309/ajg.0000000000002256.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016